ABL Diagnostics
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
ABLD | PA
Overview
Corporate Details
- ISIN(s):
- FR0000063034 (+1 more)
- LEI:
- 9695002UO0UHM0VKRH38
- Country:
- France
- Address:
- 72 ROUTE DE THIONVILLE, 57140 WOIPPY
- Website:
- https://www.ablsa.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
ABL Diagnostics is a medical technology company that develops, manufactures, and commercializes end-to-end diagnostic solutions for infectious diseases. The company specializes in genotyping, utilizing sequencing technologies such as Sanger and Next-Generation Sequencing (NGS), alongside PCR-based tests. Its product portfolio includes diagnostic assays (e.g., UltraGene), proprietary analysis software, data hosting services, and laboratory automation systems. ABL Diagnostics provides integrated decision support tools for virology and microbiology laboratories, clinicians, and researchers, aiming to improve disease management and support medical progress.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-25 18:13 |
Post-Annual General Meeting Information
Acquisition ou cession des actions de l'émetteur / Descriptif du programme de r…
|
French | 128.9 KB | ||
| 2025-05-07 18:40 |
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 4.5 MB | ||
| 2025-05-06 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 186.6 KB | ||
| 2025-05-06 17:26 |
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 4.5 MB | ||
| 2024-11-18 18:16 |
Report Publication Announcement
Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise …
|
French | 139.5 KB | ||
| 2024-11-18 18:15 |
Interim Report
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
|
French | 1.8 MB | ||
| 2024-08-30 18:00 |
Pre-Annual General Meeting Information
Modalités de mise à disposition des documents préparatoires à l'AG
|
French | 237.1 KB | ||
| 2024-08-26 14:30 |
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 9.8 MB | ||
| 2024-08-05 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
|
French | 197.7 KB | ||
| 2024-07-31 22:36 |
Report Publication Announcement
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
|
French | 144.2 KB | ||
| 2024-07-31 21:38 |
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 9.8 MB | ||
| 2024-07-31 21:38 |
Annual Report (ESEF)
Rapports financiers et d'audit annuels / Rapport financier annuel
|
French | 9.8 MB | ||
| 2024-07-03 18:00 |
Capital/Financing Update
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
|
French | 234.8 KB | ||
| 2024-07-01 18:00 |
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
|
French | 216.8 KB | ||
| 2024-05-29 18:44 |
Report Publication Announcement
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 116.5 KB |
Automate Your Workflow. Get a real-time feed of all ABL Diagnostics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ABL Diagnostics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ABL Diagnostics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Spermosens_AB_publ-logo.jpg){kind=logo}
